InvestorsHub Logo
Followers 33
Posts 5264
Boards Moderated 0
Alias Born 01/23/2019

Re: seve333 post# 414989

Tuesday, 09/05/2023 1:14:59 PM

Tuesday, September 05, 2023 1:14:59 PM

Post# of 424188
Seve333, when they start showing revenue growth from EU should spark some interest but until they have one or 2 qtrs of growing rev increases without an FDC it will be slow growth. Vascepa is too valuable to let it become shelfware. I'm guessing 2024 going into '25 something will materialize. I refuse to give up on my initial reason for investing in Amarin as the Capt would say "It's the EPA Stupid"
My interest started around 2018-19. I traded around my original investment and did well. Then 3/30/2020 hit and the rest is history. My optometrist recommended fish oil after cataract surgery. Couldn't tolerate the side effects of fish oil capsules then being a stock junky I heard about Vascepa and JT's pitch. After researching the company I asked my GP for a script she agreed given the heart issues in my family and my own high numbers so I've been taking V ever since. Honestly, I could feel the sense of well-being almost immediately. Several yrs later all my numbers across the board are where they should be and I'm 4 yrs older.🙂
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News